ScienceDaily (Aug. 11, 2011) — Scientists at the National Physical Laboratory (NPL) have mimicked the ways viruses infect human cells and deliver their genetic material. The research hopes to apply the approach to gene therapy -- a therapeutic strategy to correct defective genes such as those that cause cancer.

Gene therapy is still in its infancy, with obvious challenges around targeting damaged cells and creating corrective genes. An equally important challenge, addressed by this research, is finding ways to transport the corrective genes into the cell. This is a problem, because of the poor permeability of cell membranes.

This research describes a model peptide sequence, dubbed GeT (gene transporter), which wraps around genes, transports them through cell membranes and helps their escape from intracellular degradation traps. The process mimics the mechanisms viruses use to infect human cells.

GeT was designed to undergo differential membrane-induced folding -- a process whereby the peptide changes its structure in response to only one type of membranes. This enables the peptide, and viruses, to carry genes into the cell. Interestingly, the property also makes it antibacterial and so capable of gene transfer even in bacteria-challenged environments.

To prove the concept, the researchers used GeT to transfer a synthetic gene encoding for a green fluorescent protein -- a protein whose fluorescence in cells can be seen and monitored using fluorescence microscopy.

The design can serve as a potential template for non-viral delivery systems and specialist treatments of genetic disorders.

This research, performed at NPL, is a part of the NPL-led international research project 'Multiscale measurements in biophysical systems', which is jointly funded by NPL and the Scottish Universities Physics Alliance.

The team's article GeT peptides: a single domain approach to gene delivery, detailing this research has just been published in Chem. Commun -- the flagship journal of the Royal Society of Chemistry.

Recommend this story on Facebook, Twitter,
and Google +1:

Other bookmarking and sharing tools:

Story Source:

The above story is reprinted from materials provided by National Physical Laboratory, via EurekAlert!, a service of AAAS.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.

Journal Reference:

1. Baptiste Lamarre, Jascindra Ravi, Maxim G. Ryadnov. GeT peptides: a single-domain approach to gene delivery. Chemical Communications, 2011; 47 (32): 9045 DOI: 10.1039/C1CC13043A

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

Related Stories

Finding The ZIP-Code For Gene Therapy: Scientists Imitate Viruses To Deliver Therapeutic Genes (Sep. 2, 2009) — Australian scientists have developed a new gene therapy vector that uses the same machinery that viruses use to transport their cargo into our cells. As a result, therapeutic DNA can be transferred ...  > read more

Self-Assembled Viruses Efficiently Carry Genes And Drug Molecules Into Tumor Cells (June 2, 2008) — Korean researchers have made an artificial virus, which they have been able to use to transport both genes and drugs into the interior of cancer ...  > read more

Moving Gene Therapy Forward With Mobile DNA (May 9, 2009) — Researchers have developed a new non-viral gene technology approach. This approach overcomes side-effects associated with the current viral vectors, such as inflammation or the development of cancer. ...  > read more

Making Gene Therapy Safer: Delivering Genes Via Polymers (Sep. 16, 2007) — In work that could lead to safe and effective techniques for gene therapy, MIT researchers have found a way to fine-tune the ability of biodegradable polymers to deliver genes. Gene therapy, which ...  > read more

Search ScienceDaily